About: Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $23.24 (-7.43%)
VORNASDAQVor Biopharma Inc
Vor Biopharma Inc share price
VOR price activity
Last Price
$23.240
Change (24hr)
-1.87 USD (-7.43%)
Volume
820.18K
Volume (4w avg)
-
Open
$24.47
Day Range
$23.21 - $24.59
Previous Close
$25.10
Last Trade
09 Sep, 8:08 pm GMT+0
Delayed
09 Sep, 8:08 pm GMT+0
VOR price performance
Delayed
09 Sep, 8:08 pm GMT+0
VOR Market Signals